A Multidisciplinary Team: Approaching Diabetes Research from Many Angles
Over the last several years, the DRI’s research program has grown exponentially. Once comprised of only a handful of research teams, the Diabetes Research Institute’s faculty and staff now numbers more than 200, many of whom are investigators from new and exciting scientific disciplines that didn’t exist yesterday.
We continue to grow and expand our expertise because diseases like diabetes are rarely the result of a single cause. It makes little sense to approach them from a single angle.
At the Diabetes Research Institute, our research program is organized into four key areas where progress must be made and shared if we’re to successfully cure diabetes:
• Cellular & Molecular Biology of the Endocrine Pancreas
• Sources of Insulin Producing Cells & Regeneration
• Immunomodulation & Tolerance
• Nanotechnologies, Encapsulation, Biomaterials, Devices & Local Drug Delivery
Our teams of diabetes researchers working within these areas share knowledge and build upon each other’s results to quickly move closer to a cure.
In addition to the multidisciplinary expertise of our diabetes research faculty, the DRI’s Scientific Advisory Board (SAB) serves as our external consultant, evaluating research programs and progress, as well as providing guidance and assistance in administrative policies and issues.
The members of the DRI SAB are appointed by the Dean of the University of Miami Miller School of Medicine and the University’s Vice President and Provost.
The DRI’s Scientific Advisory Board is comprised of several distinguished scientists who have earned international recognition for their contributions to diabetes research.